Overbased Salt Additive Reduces Endocrine Disruption

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current lubricating oil additives, such as alkylphenol ethoxylates, pose endocrine disruption risks due to their estrogenic activity and poor biodegradability, leading to concerns about environmental and health impacts, and existing alternatives face challenges with odor, performance, and increased costs.

Innovation Solution

Development of an overbased salt of an oligomerized alkylhydroxyaromatic compound derived from propylene oligomers with specific boiling points, which is used in lubricating oil compositions to reduce endocrine disrupting properties, achieved through alkylation, neutralization, oligomerization, and overbasing processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If alkylphenol ethoxylates are used as lubricating oil additives, then performance benefits are achieved, but endocrine disruption risks and environmental harm increase

Engineering Contradiction:
Improveadditive performanceVSAvoidendocrine disruption
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of the additive by using oligomerized alkylhydroxyaromatic compounds with specific molecular weight distributions (average molecular weight 200-500) and controlled alkyl chain lengths (C8-C16), thereby reducing endocrine disruption while maintaining lubrication performance

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite material structure by combining oligomerized alkylhydroxyaromatic compounds with specific base oils and other compatible additives, creating a formulation that achieves performance benefits while minimizing harmful effects through synergistic interactions

Inventive Principle:
Principle #40Composite materials

2Reliability

If alkylphenol ethoxylates are used as lubricating oil additives, then lubrication performance is improved, but biodegradability and environmental compatibility worsen

Engineering Contradiction:
Improvelubrication performanceVSAvoidbiodegradability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent modifies the molecular structure parameters by limiting alkyl chain length to C8-C16 and controlling oligomerization degree, which improves biodegradability while preserving the lubrication performance through optimized molecular weight distribution

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If alternatives to alkylphenol ethoxylates are developed, then endocrine disruption is reduced, but odor, performance, and cost issues arise

Engineering Contradiction:
Improveendocrine disruptionVSAvoidadditive performance
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies local quality by carefully controlling specific molecular characteristics (alkyl chain length C8-C16, oligomerization degree, aromatic ring substitution patterns) of the additive molecules, achieving reduced endocrine disruption in specific molecular regions while maintaining overall lubrication performance through localized structural optimization

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The overbased salt significantly reduces endocrine disruption effects, as demonstrated by reproductive toxicity tests in juvenile female rats, and maintains performance benefits while minimizing environmental harm.

Implementation Method 1

Endocrine disruptors and natural estrogen share a common mechanism of action. In normal cases, estrogenic activity is produced by binding natural estrogen to an estrogen receptor (ER) within the nucleus of the cell, followed by transcriptional activation of these occupied ERs. When endocrine disruptors are present, normal estrogenic activity is supplanted when endocrine disruptors bind an ER, causing transcriptional activation of the ER even though net natural estrogen is present.

Methodology Applied
Scientific EffectEndocrine disruption mechanism:

Data Source

PatentEP2307533B1Lubricating oil additive and lubricating oil composition containing same
Publication Date: 2015.08.19 CHEVRON ORONITE CO LLC

AI summary

An overbased salt of an oligomerized alkylhydroxyaromatic compound is disclosed, wherein the alkyl group of the alkylhydroxyaromatic compound is derived from an olefin mixture comprising propylene oligomers having an initial boiling point of at least about 195°C and a final boiling point of no more than about 325°C as measured by ASTM D86. Also disclosed is a lubricating oil composition containing at least (a) a major amount of an oil of lubricating viscosity and (b) the overbased salt of the oligomerized alkylhydroxyaromatic compound.